Sponsor Pipeline

Hangzhou MacroLink Biopharmaceutical LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-24 NCT07726212 A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002 Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07726212 A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002 Advanced Esophageal Cancer Not Yet Recruiting
Disease Areas
Lung Cancer (1) Esophageal Cancer (1)
Get alerts when Hangzhou MacroLink Biopharmaceutical LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free